title: Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions.
authors.affiliation: Department of Cardiology, University Hospital La Timone, Marseille, France. thomascuisset@voila.fr
authors.forename: Thomas
authors.initials: T
authors.lastname: Cuisset
authors.forename: Harald
authors.initials: H
authors.lastname: Mudra
authors.forename: Oliver
authors.initials: O
authors.lastname: Muller
authors.forename: Pierre
authors.initials: P
authors.lastname: Vogt
authors.forename: Anne
authors.initials: A
authors.lastname: Angelillo-Scherrer
authors.forename: Kurt
authors.initials: K
authors.lastname: Huber
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors